Sabra Health Care REIT (SBRA) Q2 2026 earnings review
Strong Operations Masked by a Massive Loan Write-Down
Management called Q2 2026 a 'solid quarter,' but GAAP earnings tell a jarringly different story. Sabra swung to a $25.2 million Net Loss, driven entirely by a staggering $102.4 million provision for loan losses that decimated the bottom line. This massive write-down—which shrank the loan receivable book from $434.1M at the end of 2025 to just $115.1M—is a stark reminder of legacy underwriting risks, likely tied to troubled behavioral health assets (e.g., RCA or Landmark). However, if you strip away the bad debt, the core real estate operations are thriving. Normalized FFO reached $98.2M ($0.38/share), up from $89.2M ($0.37/share) a year ago. The Senior Housing Operating Portfolio (SHOP) remains a powerhouse, delivering 13.7% YoY same-store Cash NOI growth, while leverage plummeted to a highly conservative 4.61x. Sabra is operating extremely well, but investors must stomach the balance sheet cleanup.
🐂 Bull Case
The Managed Senior Housing portfolio continues to print double-digit growth (13.7% YoY Cash NOI). With virtually no new supply in the market and an aging demographic, operating leverage is expanding margins significantly.
Despite aggressive acquisitions ($599M YTD), active use of the ATM equity program allowed Sabra to de-lever. Net Debt to Adjusted EBITDA dropped from 5.04x in Q1 to an impressive 4.61x in Q2, providing massive dry powder.
🐻 Bear Case
A $102.4M provision for loan losses proves that management's past reassurances regarding tenant health (specifically in the behavioral health loan book) were overly optimistic. This destroys near-term GAAP profitability.
With cap rates compressing into the low 7% range, deploying another $100M+ pipeline while maintaining high historical yields requires flawless operational execution by tenant operators.
⚖️ Verdict: ⚪
Neutral to Bullish. The operational metrics are undeniable—SHOP is booming and leverage is pristine. But recording a $100M+ loan write-down while characterizing the quarter as 'solid' without prominently explaining the loss in the press release text damages management credibility.
Key Themes
Massive $102M Loan Loss Provision
The elephant in the room is the $102.4 million provision for loan losses recorded in Q2. Sabra's 'Loans receivable and other investments' balance collapsed from $434.1 million at year-end 2025 to $115.1 million today. In prior quarters, management faced questions about the health of major behavioral health loans (like RCA) and insisted talks were 'constructive'. This write-down directly contradicts the rosy narrative and wipes out quarterly earnings, highlighting the severe risk of non-core debt investments.
SHOP Portfolio Delivers Consistent Alpha
The Senior Housing - Managed (SHOP) segment continues to be Sabra's primary growth engine. Same-store Cash NOI grew an accelerating 13.7% YoY in Q2. Management is aggressively feeding this engine, closing $599 million in investments year-to-date at an estimated initial cash yield of 7.5%. The portfolio is successfully leveraging the gap between rising RevPOR and tightly managed operating expenses.
Aggressive De-Leveraging
Despite heavily funding its pipeline, Sabra achieved a remarkable reduction in leverage. Net Debt to Adjusted EBITDA dropped to 4.61x from 5.04x last quarter. This was accomplished by matching acquisitions with forward equity sales (issuing up to 0.9 million shares at $20.72) and robust operational EBITDA growth. This gives Sabra significant flexibility to absorb any macro shocks.
Favorable Macro Supply/Demand Dynamics
Management continues to cite 'virtually no new senior housing or skilled nursing supply in the foreseeable future' alongside a demographic wave where the 80+ population is expected to grow 4% annually through 2040. High construction costs and interest rates are serving as a moat for existing institutional assets, allowing Sabra's operators to push occupancy and rate simultaneously.
Avamere Transition and Rent Reset
Sabra exercised its option to reset the rent on its Avamere portfolio to a fixed $48 million annually (retroactive to Feb 2026), up from $41 million paid in 2025. This bridges the gap until the planned transition of all 26 Avamere properties to new operators in the second half of 2026, which is expected to yield $53 million in combined annualized cash rent.
Triple-Net Senior Housing Weakness
While SNF coverage improved to 2.49x, the Triple-Net Senior Housing portfolio saw drops in occupancy and coverage (down to 1.52x from 1.58x at year-end). Management dismissed this as 'simply due to the conversion of a high-performing triple-net asset to the managed portfolio,' claiming it would have otherwise been flat. While mathematically plausible, it leaves the remaining Triple-Net pool looking fundamentally weaker.
AI Integration and Tech Innovation
Sabra is positioning itself as an 'AI-enabled REIT', moving past buzzwords into practical applications. They are piloting AI-assisted deal screening and diligence workflows to accelerate investment velocity. At the property level, they have deployed 110 autonomous cleaning robots across 99 million square feet and executed 250+ inverter heat pump retrofits yielding 30%+ efficiency gains, lowering operator expense burdens.
Other KPIs
Stable and massive. Consists of $231.6M in unrestricted cash, $682.5M on the revolver, and $411.8M in forward ATM sale proceeds. This war chest allows Sabra to execute its robust SHOP acquisition strategy without tapping expensive debt markets.
Accelerating. Coverage climbed from 2.35x a year ago and 2.46x at year-end 2025. This metric effectively removes the risk of rent cuts in the core legacy portfolio, which still accounts for 47.7% of Annualized Cash NOI.
Guidance
Stable. The company simply reiterated its prior guidance. The midpoint ($1.54) implies healthy ~7% YoY growth from FY25's $1.44. Management is maintaining a characteristically conservative posture despite aggressive YTD deployment.
Stable. Reiterated from prior updates. The midpoint ($1.60) represents approximately 7.4% growth over the $1.49 delivered in 2025, easily covering the current $1.20 annualized dividend.
Stable. Reiterated. However, this target looks highly anomalous now. Sabra posted $0.16 in Q1 and $(0.10) in Q2. To hit the $0.38 midpoint, H2 2026 Net Income must violently snap back to roughly $0.32, which assumes absolutely zero recurring impairments and likely relies on gains from property sales.
Key Questions
Details on the $102M Loan Loss Provision
The $102.4M provision devastated Q2 GAAP earnings and shrank the loan book by nearly 75%. Specifically, which borrowers defaulted or were restructured to trigger this? Is this tied to the RCA maturity previously discussed, and are there any further shoes to drop in the remaining $115M balance?
Guidance Reiteration Despite the Write-Down
You reiterated FY26 Net Income guidance of $0.37-$0.39 per share despite taking a $0.10 per share net loss this quarter. Are you relying on unannounced asset sales and corresponding gains to plug this massive hole in GAAP profitability in the second half of the year?
Triple-Net Senior Housing Degradation
Coverage in the Triple-Net Senior Housing portfolio fell to 1.52x. While you attributed this to moving a high-performing asset into the Managed bucket, doesn't this imply the remaining assets in the Triple-Net pool are fundamentally weaker? At what coverage level do you intervene?
Cap Rate Compression in the SHOP Pipeline
You closed nearly $600M YTD at a 7.5% yield, but noted cap rates are compressing. With $100M+ in awarded deals and a robust pipeline, are you having to lower your underwriting standards or accept lower initial yields (e.g., low 7s) to win these deals?